For the risk stratification of indeterminate thyroid nodules
For the risk stratification of indeterminate thyroid nodules
Please visit us at ENDOExpo 2024 (Booth 626)
In a patient with an indeterminate thyroid nodule and no identified mutations, the use of microRNA signatures helped inform a high risk of malignancy. This clinical case highlights how microRNA profiling, when combined with mutational analysis, can provide deep insights to help improve the risk stratification of indeterminate thyroid nodules.1-3 Clinical Case Overview A 48-year-old […]
Signaling pathways are complex communication networks that guide how cells function and respond to their environment. They regulate every aspect of cellular function, including growth, division, differentiation, and death. Signaling pathways involve a series of molecular events, including signal reception, amplification, and distribution, as well as the execution of responses.1 microRNAs are key regulators of
microRNA Helps Regulate Signaling Pathways in Thyroid Cancer Read More »
ThyGeNEXT®+ThyraMIR®v2 is a unique combination testing platform that utilizes an assessment of the most common mutations associated with all types of thyroid carcinoma and microRNA signatures that provide deep insight into the epigenetic regulation of cancer signaling pathways. The assessment of microRNAs with ThyraMIRv2 enables the testing platform to help rule in malignancy, even in
ThyraMIRv2 Provides Insight Into Signaling Pathway Genes Read More »